Американское общество гирудотерапии

Activity-Dependent Modulation of Tonic GABA Currents by Endocannabinoids in Hirudo verbana

Basic science published in Front Synaptic Neurosci (2022)

Последнее обновление: June 18, 2026Рецензент: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportГеномика и протеомикаФармакология секрета слюнных желёзPaulsen RT, Burrell BD · Frontiers in synaptic neuroscience, 2022

Abstract

Endocannabinoids are lipid neuromodulators that are synthesized on demand and primarily signal in a retrograde manner to elicit depression of excitatory and inhibitory synapses. Despite the considerable interest in their potential analgesic effects, there is evidence that endocannabinoids can have both pro-nociceptive and anti-nociceptive effects. The mechanisms contributing to the opposing effects of endocannabinoids in nociception need to be better understood before cannabinoid-based therapies can be effectively utilized to treat pain. Using the medicinal leech, Hirudo verbana, this work investigates whether endocannabinoids modulate tonic inhibition onto non-nociceptive afferents. In voltage clamp recordings, we analyzed changes in the tonic inhibition in pressure-sensitive (P) cells following pre-treatment with endocannabinoids, 2-arachidonoylglycerol (2-AG) or anandamide (AEA). We also tested whether high frequency stimulation (HFS) of nociceptive (N) cells could also modulate tonic inhibition. Both endocannabinoid application and N cell HFS depressed tonic inhibition in the P cell. Depression of tonic inhibition by N cell HFS was blocked by SB 366791 (a TRPV1 inhibitor). SB 366791 also prevented 2-AG-and AEA-induced depression of tonic inhibition. HFS-induced depression was not blocked by tetrahydrolipstatin (THL), which prevents 2-AG synthesis, nor AM 251 (a CB1 receptor inverse agonist). These results illustrate a novel activity-dependent modulation of tonic GABA currents that is mediated by endocannabinoid signaling and is likely to play an important role in sensitization of non-nociceptive afferent pathways.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Резюме

Endocannabinoids 2-AG and anandamide depress tonic GABA inhibition in Hirudo verbana pressure-sensitive cells via TRPV1, providing a model for nociceptive sensitization mediated by endocannabinoids.

Почему это важно для гирудотерапии

This study used the medicinal leech Hirudo verbana to investigate whether endocannabinoids modulate tonic GABA inhibition onto non-nociceptive afferents, finding that both exogenously applied endocannabinoids (2-AG and AEA) and high-frequency stimulation of nociceptive neurons depressed tonic inhibition in pressure-sensitive cells. The depression was blocked by the TRPV1 inhibitor SB 366791 but not by 2-AG synthesis inhibitors or CB1 receptor inverse agonists, suggesting a novel activity-dependent endocannabinoid modulation pathway relevant to sensitization of non-nociceptive afferents. This work is relevant to ASH's domain as it leverages the medicinal leech nervous system as a model to study neuromodulatory mechanisms of nociception. The study is purely basic neuroscience with no investigation of therapeutic applications, the leech secretome, or hirudotherapy.

Цитирование

Activity-Dependent Modulation of Tonic GABA Currents by Endocannabinoids in Hirudo verbana.

Paulsen RT, Burrell BD · Frontiers in synaptic neuroscience, 2022

Связанный клинический контекст

Узнайте, как это исследование связано с клинической практикой

Добавлено в библиотеку ASH: May 27, 2026 · Последнее обновление сайта: June 18, 2026

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.